EU centralized/decentralized procedures for devices: likely outlook now?
This article was originally published in Clinica
Executive Summary
The involvement of the European Medicines Agency in the future EU regulation of medical devices and diagnostics would be a Herculean task with huge financial and organizational issues. That was the view expressed by MEPs Dr Peter Liese and Rebecca Taylor last week at the European Parliament in Brussels.
You may also be interested in...
EU Experts Want One-Stop-Shop EU Governance That Mimics Best Of Other Jurisdictions
It may be blue sky thinking to surmise how a new EU medtech regulatory governance structure could evolve. But with change on the horizon, experts see exciting opportunities.
Second EU MDR Notified Body Designated In France
Four years after the designation of the first notified body in France under the Medical Device Regulation, AFNOR Certification has been named too.
EU Regulatory Experts Support Notified Bodies, But Argue For Greater Consistency
Notified bodies have been a pivotal part of the EU medtech regulatory system since it was first launched in the 1990s. Where might they fit within a new medtech regulatory governance structure? Panelists on a recent vodcast grappled with the question.